Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improving AZT efficacy

J Balzarini, B Degrève, E De Clercq

    Nature Medicine
    |February 14, 1998
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents.

    Nucleosides, nucleotides & nucleic acids·2001
    Same author

    2'-O-Acyl/alkyl-substituted arabinosyl nucleosides as inhibitors of human mitochondrial thymidine kinase.

    Biochemical pharmacology·2001
    Same author

    Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase.

    Molecular pharmacology·2001
    Same author

    Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine.

    Molecular pharmacology·2000
    Same author

    Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase.

    FEBS letters·2000
    Same author

    Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV).

    Gene therapy·2000
    Same journal

    Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

    Nature medicine·2026
    Same journal

    Immune aging biomarkers for clinical trials.

    Nature medicine·2026
    Same journal

    Lassa fever countermeasures gather pace.

    Nature medicine·2026
    Same journal

    Why high scores do not mean application readiness for health AI.

    Nature medicine·2026
    Same journal

    Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.

    Nature medicine·2026
    Same journal

    Biological aging might help to explain the rising risk of early-onset cancer.

    Nature medicine·2026
    See all related articles